Abstract

The treatment of upper gastrointestinal bleeding (UGIB) remains one of the complex problems of clinical practice. In the structure of UGIB, 30%-60% of cases are occupied by bleeding of ulcerative etiology. Success in treating patients with ulcerative gastroduodenal bleeding is possible only with the use of an integrated approach that includes endoscopic, medicinal, endovascular, and surgical hemostasis technologies. In contrast, endoscopic hemostasis (EH) is crucial in the treatment of such patients. The use of modern advances in endoscopy can significantly improve the treatment results of patients with UGIB, reducing the number of operations and mortality in this severely affected group of patients. Modern therapeutic endoscopy has a wide arsenal of tools that can reliably stop bleeding. They differ from each other in the nature of impact, effectiveness, availability, safety, and cost. This article presents an overview of the technological and clinical features of hemostasis, modern views on the choice and application of methods of EH for ulcerative gastroduodenal bleeding.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call